{"entity":{"type":"insider","cik":"0001522751","url":"/insider/0001522751","json_url":"/insider/0001522751.json","name":"DAVE KAUSHIK J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":3,"first":"2013-05-08","last":"2016-04-18","span_basis":"filed_date"},"name_variants":[{"name":"DAVE KAUSHIK J","source":"filing","n_filings":3,"first_seen":"2013-05-08","last_seen":"2016-04-18"}],"transactions":[{"id":3219136,"accession":"0001213900-16-012634","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-16-012634","line_url":"/filing/0001213900-16-012634","is_derivative":false,"issuer_cik":"0001388320","issuer_name":"Actinium Pharmaceuticals, Inc.","issuer_ticker":"ATNM","issuer_name_source":null,"issuer_url":"/issuer/0001388320","owner_cik":"0001522751","owner_name":"DAVE KAUSHIK J","owner_display_name":"DAVE KAUSHIK J","owner_url":"/insider/0001522751","role":"Director, Officer (CEO and Interim CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Interim CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.018,"price_display":"2.02","price_state":"stated","total_value":20180.0,"total_display":"20,180.00","total_whole":"20,180","shares_owned_after":86500.0,"shares_owned_after_display":"86,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-18","scope":"insider","n_lines":2},{"id":5066796,"accession":"0001181431-13-032916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-032916","line_url":"/filing/0001181431-13-032916#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001522751","owner_name":"DAVE KAUSHIK J","owner_display_name":"DAVE KAUSHIK J","owner_url":"/insider/0001522751","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48000.0,"shares_display":"48,000","price_per_share":4.0114,"price_display":"4.01","price_state":"stated","total_value":192547.2,"total_display":"192,547.20","total_whole":"192,547","shares_owned_after":265028.0,"shares_owned_after_display":"265,028","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-03","filed_date":"2013-06-05","scope":"insider"},{"id":5169355,"accession":"0001181431-13-026288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-026288","line_url":"/filing/0001181431-13-026288#line-2","is_derivative":false,"issuer_cik":"0001016169","issuer_name":"ANTARES PHARMA, INC.","issuer_ticker":"ATRS","issuer_name_source":null,"issuer_url":"/issuer/0001016169","owner_cik":"0001522751","owner_name":"DAVE KAUSHIK J","owner_display_name":"DAVE KAUSHIK J","owner_url":"/insider/0001522751","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":4.0201,"price_display":"4.02","price_state":"stated","total_value":48241.2,"total_display":"48,241.20","total_whole":"48,241","shares_owned_after":206106.0,"shares_owned_after_display":"206,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-06","filed_date":"2013-05-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001388320","name":"Actinium Pharmaceuticals, Inc.","url":"/issuer/0001388320","role":"Director, Officer (CEO and Interim CFO)","n_filings":1,"first_seen":"2016-04-18","last_seen":"2016-04-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001016169","name":"ANTARES PHARMA, INC.","url":"/issuer/0001016169","role":"Officer (Executive Vice President)","n_filings":2,"first_seen":"2013-05-08","last_seen":"2013-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001522751","retrieved_at":"2026-08-22T12:11:09+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}